Translation Acceleration Grant 2017

Movember Translation Acceleration Grant

Prostate Cancer Canada (PCC) invites applications for investigator-initiated Movember Translation Acceleration Grants (TAG) that address a significant issue in the management of prostate cancer. The intent of this program is not to support new discovery. Rather proposals should leverage existing knowledge and capabilities to accelerate impact without overlapping currently funded Prostate Cancer Canada and Movember initiatives.

While the area of prostate cancer covered by the proposal is open, the emphasis of this funding opportunity is to develop an intervention that can be further studied first-in-man, in the form of an interventional or observational study immediately following the funding period. It is expected that a multidisciplinary and multi-institutional approach will be required and each application may consist of independent investigators based in multiple institutions with a lead Principal Investigator. This competition is open to projects studying any stage of the prostate cancer journey but PCC will only consider projects that are completely focused on prostate cancer.
 
This opportunity is awarded by Prostate Cancer Canada and proudly funded by the Movember Foundation.
smaller-still.jpg
 
Award amount: up to $1,500,000 over 3 years

Key dates:
Registration Deadline: December 21, 2016 at 5:00 p.m. Eastern
Full Application Deadline: January 31, 2017 at 5:00 p.m. Eastern
Funding Start Date: April 1, 2017

The online application is available at https://pccgrants.smartsimple.ca  
Movember Translation Acceleration Grant (updated December 21, 2016) RFA document
FAQs and Tipsheet

 
For more information, contact:
 
Jenna Fong, PhD
Manager, Research
416 - 441-2131, Ext. 243

jenna.fong@prostatecancer.ca

 

Joanne Reynolds
Manager, Research Operations
416-441-2131, Ext. 226
joanne.reynolds@prostatecancer.ca
 
 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada.
More

Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More


Click here for news archive